A new endogenous differentiating factor (myelopeptide-4) for myeloid cells.
Lab research · 2000
- What was studied
- Human leukemia cell lines; porcine marrow-derived peptide
- Main finding
- MP-4 (FRPRIMTP), isolated from porcine marrow culture, altered differentiation markers and morphology in HL-60 and K-562 leukemia cell lines. This was not a leukemia treatment trial.
Study data at a glance
- Participants or experimental model
- Human leukemia cell lines; porcine marrow-derived peptide
- Reported results
- MP-4 (FRPRIMTP), isolated from porcine marrow culture, altered differentiation markers and morphology in HL-60 and K-562 leukemia cell lines. This was not a leukemia treatment trial.
Study limitations and source details
Study limitations
- Preclinical findings do not establish human benefit or safety.
- Abstract only. Full methods and independent replication remain unconfirmed.
Source details
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Abstract reviewed
Sources checked
Citation
Strelkov LA, Mikhailova AA, Fonina LA, Petrov RV. A new endogenous differentiating factor (myelopeptide-4) for myeloid cells. FEBS letters
Study source ↗ · DOI 10.1016/s0014-5793(00)01344-2 · Bibliography entry · Link to this summary